Johan Farngren (Former)

1 – 7 of 7

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/294c1a9a-bb3f-4029-9315-9ac5fe1b1b21?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2019
Mark Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes
Farngren, Johan ^LU and Ahrén, Bo ^LU (2019) In Metabolism: Clinical and Experimental 99. p.25-31
- Contribution to journal › Article
Mark Glucagon Counter-Regulation to Hypoglycemia During Incretin-Based Therapy
Farngren, Johan ^LU (2019) In Lund University, Faculty of Medicine Doctoral Dissertation Series 2019(66).
- Thesis › Doctoral thesis (compilation)
2018
Mark Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes : A randomized, placebo-controlled study
Farngren, Johan ^LU ; Persson, Margaretha ^LU and Ahrén, Bo ^LU (2018) In Diabetes, Obesity and Metabolism 20(8). p.1911-1920
- Contribution to journal › Article
2016
Mark Effect of the GLP-1 Receptor Agonist Lixisenatide on Counter-Regulatory Responses to Hypoglycemia in Subjects With Insulin-Treated Type 2 Diabetes.
Farngren, Johan ^LU ; Persson, Margaretha ^LU and Ahrén, Bo ^LU (2016) In Diabetes Care 39(2). p.242-249
- Contribution to journal › Article
2015
Mark Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin.
Tura, Andrea ; Farngren, Johan ^LU ; Schweizer, Anja ; Foley, James E ; Pacini, Giovanni and Ahrén, Bo ^LU (2015) In International Journal of Endocrinology 2015.
- Contribution to journal › Article
2014
Mark Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes.
Farngren, Johan ^LU ; Persson, Margaretha ^LU ; Schweizer, A ; Foley, J E and Ahrén, Bo ^LU (2014) In Diabetes, Obesity and Metabolism 16(9). p.812-818
- Contribution to journal › Article
2012
Mark Vildagliptin Reduces Glucagon during Hyperglycemia and Sustains Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
Farngren, Johan ^LU ; Persson, Margaretha ^LU ; Schweizer, Anja ; Foley, James E and Ahrén, Bo ^LU (2012) In The Journal of clinical endocrinology and metabolism 97(10). p.3799-3806
- Contribution to journal › Article